Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Critical Reviews in Toxicology | journal | 2.041 Q1 | 129 | 12 | 46 | 3053 | 316 | 45 | 6.88 | 254.42 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.839 Q1 | 70 | 7 | 41 | 1515 | 253 | 41 | 5.39 | 216.43 | |
3 | Natural Product Reports | journal | 2.895 Q1 | 211 | 38 | 112 | 6619 | 543 | 112 | 5.00 | 174.18 | |
4 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 0.860 Q1 | 99 | 9 | 26 | 1490 | 75 | 26 | 2.88 | 165.56 | |
5 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.133 Q4 | 50 | 41 | 154 | 6279 | 24 | 154 | 0.08 | 153.15 | |
6 | Studies in Natural Products Chemistry | book series | 0.335 Q3 | 49 | 76 | 20 | 10754 | 10 | 17 | 0.00 | 141.50 | |
7 | Progress in Drug Research | book series | 0.766 Q1 | 46 | 16 | 41 | 2040 | 93 | 38 | 2.72 | 127.50 | |
8 | Reviews in Contemporary Pharmacotherapy | journal | 0.229 Q3 | 18 | 17 | 93 | 2155 | 94 | 93 | 1.13 | 126.76 | |
9 | Expert Opinion on Therapeutic Targets | journal | 0.146 Q3 | 106 | 44 | 158 | 5137 | 29 | 156 | 0.32 | 116.75 | |
10 | Current Drug Metabolism | journal | 122 | 20 | 0 | 2311 | 0 | 0 | 0.00 | 115.55 | ||
11 | Handbook of Analytical Separations | book series | 13 | 43 | 0 | 4692 | 0 | 0 | 0.00 | 109.12 | ||
12 | Progress in Medicinal Chemistry | journal | 0.600 Q2 | 38 | 6 | 19 | 646 | 37 | 11 | 2.31 | 107.67 | |
13 | Current Pharmaceutical Biotechnology | journal | 97 | 23 | 0 | 2223 | 0 | 0 | 0.00 | 96.65 | ||
14 | Drug Safety | journal | 0.961 Q1 | 140 | 75 | 226 | 6578 | 812 | 219 | 3.38 | 87.71 | |
15 | IDrugs : the investigational drugs journal | journal | 0.144 Q3 | 39 | 69 | 241 | 5920 | 63 | 237 | 0.26 | 85.80 | |
16 | Advanced Drug Delivery Reviews | journal | 0.967 Q1 | 366 | 98 | 348 | 8251 | 946 | 328 | 2.30 | 84.19 | |
17 | Cellular and Molecular Life Sciences | journal | 2.400 Q1 | 261 | 182 | 480 | 14983 | 1747 | 474 | 3.79 | 82.32 | |
18 | Expert Opinion on Emerging Drugs | journal | 0.243 Q3 | 54 | 25 | 63 | 2057 | 49 | 61 | 0.80 | 82.28 | |
19 | Clinical Pharmacokinetics | journal | 1.632 Q1 | 184 | 68 | 207 | 5484 | 1126 | 200 | 4.40 | 80.65 | |
20 | Toxicology and Industrial Health | journal | 0.556 Q2 | 69 | 34 | 170 | 2662 | 290 | 168 | 1.98 | 78.29 | |
21 | Expert Opinion on Pharmacotherapy | journal | 0.119 Q4 | 93 | 89 | 16 | 6820 | 4 | 16 | 0.25 | 76.63 | |
22 | Toxin Reviews | journal | 0.336 Q3 | 54 | 12 | 92 | 873 | 73 | 89 | 0.77 | 72.75 | |
23 | Expert Opinion on Investigational Drugs | journal | 0.365 Q2 | 117 | 278 | 449 | 19174 | 510 | 446 | 1.17 | 68.97 | |
24 | Drug Metabolism and Personalized Therapy | journal | 0.175 Q3 | 38 | 34 | 48 | 2316 | 25 | 48 | 0.42 | 68.12 | |
25 | BioDrugs | journal | 0.187 Q3 | 79 | 81 | 251 | 5271 | 174 | 240 | 0.79 | 65.07 | |
26 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 5 | 35 | 0 | 2174 | 0 | 0 | 0.00 | 62.11 | ||
27 | Side Effects of Drugs Annual | book series | 0.105 Q4 | 9 | 51 | 153 | 3161 | 4 | 153 | 0.03 | 61.98 | |
28 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.126 Q4 | 5 | 19 | 59 | 1135 | 16 | 57 | 0.25 | 59.74 | |
29 | Investigational New Drugs | journal | 0.704 Q1 | 97 | 36 | 130 | 2116 | 264 | 129 | 1.40 | 58.78 | |
30 | Pharmacogenomics | journal | 100 | 35 | 0 | 1937 | 0 | 0 | 0.00 | 55.34 | ||
31 | Current Opinion in Drug Discovery and Development | journal | 0.669 Q1 | 85 | 77 | 83 | 3924 | 161 | 78 | 1.94 | 50.96 | |
32 | Current Opinion in Molecular Therapeutics | journal | 0.283 Q3 | 67 | 90 | 93 | 4584 | 63 | 87 | 0.68 | 50.93 | |
33 | Drugs of the Future | journal | 0.237 Q3 | 46 | 85 | 701 | 4223 | 345 | 701 | 0.99 | 49.68 | |
34 | In Vivo | journal | 0.364 Q2 | 72 | 110 | 260 | 5450 | 283 | 260 | 0.94 | 49.55 | |
35 | Apoptosis : an international journal on programmed cell death | journal | 0.577 Q1 | 128 | 62 | 148 | 3054 | 189 | 148 | 0.92 | 49.26 | |
36 | Neuropsychopharmacology | journal | 1.965 Q1 | 249 | 153 | 369 | 7399 | 1630 | 336 | 4.47 | 48.36 | |
37 | Mutation Research - DNA Repair | journal | 2.461 Q1 | 75 | 75 | 201 | 3594 | 709 | 200 | 3.76 | 47.92 | |
38 | Drugs of Today | journal | 0.165 Q3 | 57 | 111 | 298 | 5309 | 146 | 295 | 0.43 | 47.83 | |
39 | Journal of Computer-Aided Molecular Design | journal | 1.111 Q1 | 119 | 88 | 215 | 4093 | 630 | 213 | 2.50 | 46.51 | |
40 | Expert Opinion on Therapeutic Patents | journal | 0.439 Q2 | 88 | 150 | 402 | 6755 | 392 | 397 | 1.04 | 45.03 | |
41 | NeuroToxicology | journal | 0.695 Q2 | 133 | 105 | 271 | 4713 | 533 | 266 | 1.75 | 44.89 | |
42 | Psychopharmacology | journal | 1.409 Q1 | 214 | 301 | 1033 | 13437 | 3447 | 1003 | 3.06 | 44.64 | |
43 | Receptors and Channels | journal | 1.269 Q1 | 44 | 19 | 76 | 846 | 137 | 76 | 1.94 | 44.53 | |
44 | Chemico-Biological Interactions | journal | 0.700 Q1 | 144 | 95 | 369 | 4186 | 725 | 367 | 1.79 | 44.06 | |
45 | Neuropharmacology | journal | 2.141 Q1 | 191 | 283 | 546 | 12355 | 2431 | 542 | 4.11 | 43.66 | |
46 | International Immunopharmacology | journal | 149 | 219 | 579 | 9416 | 784 | 569 | 1.25 | 43.00 | ||
47 | International Journal of Neuropsychopharmacology | journal | 0.432 Q2 | 125 | 47 | 66 | 1989 | 65 | 66 | 0.98 | 42.32 | |
48 | Journal of Autonomic Pharmacology | journal | 26 | 36 | 132 | 1516 | 108 | 132 | 0.87 | 42.11 | ||
49 | Toxicology | journal | 0.528 Q2 | 176 | 233 | 468 | 9669 | 774 | 464 | 1.43 | 41.50 | |
50 | Mutagenesis | journal | 0.772 Q1 | 102 | 74 | 269 | 3062 | 557 | 267 | 1.90 | 41.38 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®